3D model is for representation purpose only.
.
.
SRRARRSPRHLGSGC | 4-maleimidobutyric acid | Doxorubicin |
Identification | |
---|---|
ConjuPepDB ID | cpd01251 |
Smiles | |
Molecular weight | 2403.11 |
Molecular formula | C101H154N34O33S |
Chemical name | Peptide information |
Sequence (one letter) | SRRARRSPRHLGSGC |
Length | 15 |
Peptide name | N/A |
External ID | |
---|---|
CAS number | 916443-64-6 |
Other information | |
---|---|
Application | Antitumor therapy, colon and breast tumors |
Additional function | improved efficacy and circumventing resistance |
Pharmacological class | anticancer |
Conjugate type | sulfide |
Linker | N/A |
Linker Type | 4-maleimidobutyric acid |
Small molecule | Doxorubicin |
Small molecule CAS | 23214-92-8 |
Structure method | 1H NMR, HPLC |
NMR solvent | DMSO-d6 |
Calculated properties | |
---|---|
LogP | -19.86716 |
Rotatable bonds | 68 |
H bond donor | 40 |
H bond acceptor | 50 |
Polar surface area (PSA) | 1107.33000 |
Citations | |||||
---|---|---|---|---|---|
ID | Title | Year | Authors | Journal | DOI |
Improved Therapeutic Efficacy of Doxorubicin through Conjugation with a Novel Peptide Drug Delivery Technology (Vectocell) | 2006 | Meyer-Losic, Florence; Quinonero, Jerome; Dubois, Vincent; Alluis, Bertrand; Dechambre, Mireille; Michel, Matthieu; Cailler, Francoise; Fernandez, Anne-Marie; Trouet, Andre; Kearsey, Jonathan | Journal of Medicinal Chemistry |